403 related articles for article (PubMed ID: 33599882)
21. Sequential implementation of DSC-MR perfusion and dynamic [
Steidl E; Langen KJ; Hmeidan SA; Polomac N; Filss CP; Galldiks N; Lohmann P; Keil F; Filipski K; Mottaghy FM; Shah NJ; Steinbach JP; Hattingen E; Maurer GD
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1956-1965. PubMed ID: 33241456
[TBL] [Abstract][Full Text] [Related]
22. Potential for differentiation of glioma recurrence from radionecrosis using integrated
Sogani SK; Jena A; Taneja S; Gambhir A; Mishra AK; D'Souza MM; Verma SM; Hazari PP; Negi P; Jadhav GK
Neurol India; 2017; 65(2):293-301. PubMed ID: 28290392
[TBL] [Abstract][Full Text] [Related]
23. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.
Kim M; Jung SY; Park JE; Jo Y; Park SY; Nam SJ; Kim JH; Kim HS
Eur Radiol; 2020 Apr; 30(4):2142-2151. PubMed ID: 31828414
[TBL] [Abstract][Full Text] [Related]
24. PET/MRI: Multiparametric imaging of brain tumors.
Ferda J; Ferdová E; Hes O; Mraček J; Kreuzberg B; Baxa J
Eur J Radiol; 2017 Sep; 94():A14-A25. PubMed ID: 28283219
[TBL] [Abstract][Full Text] [Related]
25. Comparison of unsupervised classification methods for brain tumor segmentation using multi-parametric MRI.
Sauwen N; Acou M; Van Cauter S; Sima DM; Veraart J; Maes F; Himmelreich U; Achten E; Van Huffel S
Neuroimage Clin; 2016; 12():753-764. PubMed ID: 27812502
[TBL] [Abstract][Full Text] [Related]
26. Imaging of intratumoral heterogeneity in high-grade glioma.
Hu LS; Hawkins-Daarud A; Wang L; Li J; Swanson KR
Cancer Lett; 2020 May; 477():97-106. PubMed ID: 32112907
[TBL] [Abstract][Full Text] [Related]
27. Grading and outcome prediction of pediatric diffuse astrocytic tumors with diffusion and arterial spin labeling perfusion MRI in comparison with 18F-DOPA PET.
Morana G; Piccardo A; Tortora D; Puntoni M; Severino M; Nozza P; Ravegnani M; Consales A; Mascelli S; Raso A; Cabria M; Verrico A; Milanaccio C; Rossi A
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2084-2093. PubMed ID: 28752225
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic yield of simultaneous dynamic contrast-enhanced magnetic resonance perfusion measurements and [
Henriksen OM; Hansen AE; Muhic A; Marner L; Madsen K; Møller S; Hasselbalch B; Lundemann MJ; Scheie D; Skjøth-Rasmussen J; Poulsen HS; Larsen VA; Larsson HBW; Law I
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4677-4691. PubMed ID: 35907033
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous evaluation of brain tumour metabolism, structure and blood volume using [(18)F]-fluoroethyltyrosine (FET) PET/MRI: feasibility, agreement and initial experience.
Henriksen OM; Larsen VA; Muhic A; Hansen AE; Larsson HBW; Poulsen HS; Law I
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):103-112. PubMed ID: 26363903
[TBL] [Abstract][Full Text] [Related]
30. Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas.
Kong Z; Yan C; Zhu R; Wang J; Wang Y; Wang Y; Wang R; Feng F; Ma W
Neuroimage Clin; 2018; 20():51-60. PubMed ID: 30069427
[TBL] [Abstract][Full Text] [Related]
31. Clinical PET/MR Imaging in Dementia and Neuro-Oncology.
Henriksen OM; Marner L; Law I
PET Clin; 2016 Oct; 11(4):441-52. PubMed ID: 27593248
[TBL] [Abstract][Full Text] [Related]
32. Advanced MR imaging and
Piccardo A; Tortora D; Mascelli S; Severino M; Piatelli G; Consales A; Pescetto M; Biassoni V; Schiavello E; Massollo M; Verrico A; Milanaccio C; Garrè ML; Rossi A; Morana G
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1685-1694. PubMed ID: 31030232
[TBL] [Abstract][Full Text] [Related]
33. Advanced magnetic resonance imaging in glioblastoma: a review.
Shukla G; Alexander GS; Bakas S; Nikam R; Talekar K; Palmer JD; Shi W
Chin Clin Oncol; 2017 Aug; 6(4):40. PubMed ID: 28841802
[TBL] [Abstract][Full Text] [Related]
34. TSPO-PET and diffusion-weighted MRI for imaging a mouse model of infiltrative human glioma.
Pigeon H; Pérès EA; Truillet C; Jego B; Boumezbeur F; Caillé F; Zinnhardt B; Jacobs AH; Le Bihan D; Winkeler A
Neuro Oncol; 2019 Jun; 21(6):755-764. PubMed ID: 30721979
[TBL] [Abstract][Full Text] [Related]
35. Combining
Girard A; Le Reste PJ; Metais A; Carsin Nicol B; Chiforeanu DC; Bannier E; Campillo-Gimenez B; Devillers A; Palard-Novello X; Le Jeune F
J Neurooncol; 2021 Dec; 155(3):287-295. PubMed ID: 34686993
[TBL] [Abstract][Full Text] [Related]
36. Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches.
Dhermain F
Chin J Cancer; 2014 Jan; 33(1):16-24. PubMed ID: 24384237
[TBL] [Abstract][Full Text] [Related]
37. Radiotherapy target volume definition in newly diagnosed high grade glioma using
Dissaux G; Dissaux B; Kabbaj OE; Gujral DM; Pradier O; Salaün PY; Seizeur R; Bourhis D; Ben Salem D; Querellou S; Schick U
Radiother Oncol; 2020 Sep; 150():164-171. PubMed ID: 32580001
[TBL] [Abstract][Full Text] [Related]
38. Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging.
Fink JR; Muzi M; Peck M; Krohn KA
J Nucl Med; 2015 Oct; 56(10):1554-61. PubMed ID: 26294301
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
[TBL] [Abstract][Full Text] [Related]
40. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]